ROCK inhibition suppresses glioblastoma via a PTEN-associated reduction in PI3K/AKT signaling
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.ROCK inhibitors Thiazovivin and GSK 429286 show potential as glioblastoma treatments. Thiazovivin demonstrated greater efficacy and selectivity, reducing cancer cell viability by impacting PTEN and PI3K/AKT signaling pathways.
Area Of Science
- Oncology
- Molecular Biology
- Pharmacology
Background
- Glioblastoma is the most aggressive primary brain tumor.
- ROCK signaling plays a role in glioblastoma progression.
- PTEN-mediated inhibition of PI3K signaling is crucial in glioblastoma.
Purpose Of The Study
- To investigate the role of ROCK in PI3K signaling regulated by PTEN.
- To evaluate Thiazovivin and GSK 429286 as potential glioblastoma therapeutics.
- To assess the impact of ROCK inhibitors on glioblastoma cell viability and PTEN/PI3K/AKT pathway.
Main Methods
- Cytotoxicity assays (MTT, xCELLigence) on U87 MG and L929 cells.
- ELISA for PTEN protein levels.
- Western blot for p-Akt and PTEN protein expression.
- BCA assay for total protein concentration.
Main Results
- Both Thiazovivin and GSK 429286 significantly reduced glioblastoma cell viability.
- Thiazovivin exhibited a more potent cytotoxic effect (IC50: 11.02 µM) than GSK 429286 (IC50: 89.58 µM).
- ROCK inhibitors increased PTEN activity and expression, and decreased p-Akt levels, indicating PI3K/AKT pathway inhibition.
Conclusions
- ROCK inhibitors demonstrate significant cytotoxic effects on glioblastoma cells.
- Thiazovivin shows promise as a more selective and potent therapeutic agent.
- ROCK inhibitors may represent a novel therapeutic strategy for glioblastoma by modulating PTEN/PI3K/AKT signaling.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...